|
Vivek P. Chavda, MPharm, is currently working as an Assistant Professor in the Department of Pharmaceutics and Pharmaceutical Technology at the L. M. College of Pharmacy, Ahmedabad, Gujarat, India. Before joining academia, he served in the biologics industry for almost eight years in research and development with two successful regulatory filings at Lupin Biotech (Pune) and Dr. Reddy's Laboratory (Hyderabad). He has more than 150 national and international publications, nearly 20 book chapters, several books, one patent in progress, as well as numerous newsletter articles to his credit. His research interests include development of biologics processes and formulations, medical device development, nano-diagnostics, long-acting parenteral formulations, and nano-vaccines. He earned his BPharm and MPharm degrees (with gold medals) at Gujarat Technological University, Gujarat, India. Zhe-Sheng (Jason) Chen, MD, PhD, is currently a Professor at the College of Pharmacy and Health Sciences at St. John's University, Queens, New York, USA. Dr. Chen is an editor-in-chief of the Journal of Cancer Research Updates and New Developments on Chemistry, an editor of the African Journal of Pharmacy and Pharmacology, a regional editor of Recent Patents on Anticancer Drugs Discovery, a guest editor of Current Pharmaceutical Biotechnology, as well as an editorial board member of more than 20 journals and a reviewer of more than 170 peer-reviewed journals. He is also an ad hoc reviewer of grants for The National Institutes of Health (USA), NCI Special Emphasis Review Panel, and OmniBus SEP-10, as well as a State Grant Reviewer for Louisiana and reviewer for grants for New Zealand, Poland, China, Hungary, Netherlands, etc. As a consultant to pharmaceutical, biotechnology and health industry organizations, Dr. Chen commands invitations for presentations, keynote addresses, and conference chairman.
|
